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Recovery from influenza virus infection is dependent on T cell functions which can be provided either by CD8 or CD4
T cells. To identify the functions involved in recovery promoted by CD4 T cells, we have studied the course of the
infection in B-cell deficient mMT mice which had been depleted of CD8 T cells by antibody treatment. Upon infection
with PR8 [A/PR/8/34(H1N1)], such B- and CD8 T cell-deficient mice mounted strong CD4 T cell responses that were
comparable in size and cytokine secretion to those seen in intact mice. Yet, these B- and CD8 T cell-deficient mice
could not clear the infection, in contrast to (CD8-depleted) mice containing both B- and CD4 T cells. These findings
indicate that the promotion of the T-dependent antibody response is an indispensable component in the CD4 T cell-
dependent recovery process. q 1997 Academic Press
INTRODUCTION idea that CD4 T cells promote recovery through promo-
tion of an antibody response. The problem, however, was
In mammals, influenza type A virus typically produces
to verify that the local antibody concentrations in the
a cytopathic infection of the epithelium that covers the
RT required for virus clearance in the passive treatment
airways of both the upper and the lower respiratory tract
protocol could actually be achieved by the active anti-
(RT). The infection in mice has been used extensively in
body response. Furthermore, the failure of individual CD4
the past to study host defense mechanisms that operate
T cell clones to effect clearance did not exclude the
at these sites of the RT. It is now firmly established that
possibility that the endogenous polyspecific CD4 T cell
recovery from this infection is dependent on T cell func-
response would be effective. The CD4 T cells clones,
tions, i.e., does not occur in athymic nude or experimen-
though all of type 1, may not have secreted the most
tally T cell-depleted mice (Wells et al., 1981; Doherty et
effective combination of cytokines or may not have mi-
al., 1992). More recent studies revealed that both CD8
grated properly in vivo to the site of infection. It was
and CD4 T cells are capable of promoting recovery
important, therefore, to assess the efficacy of the active
(Doherty et al., 1992), apparently through distinct mecha-
polyclonal CD4 T cell response on its own in the recovery
nisms, as CD8 T cells required a MHC-restricted interac-
process. This was done by studying the course of the
tion with infected epithelial cells (Hou and Doherty, 1995),
viral infection in mMT mice (Kitamura et al., 1991) which
while this was not the case for CD4 T cells (Topham et
are B cell-deficient because of a disrupted membrane
al., 1996a). The latter observation left open the possibili-
IgM gene and which were additionally depleted of CD8
ties that CD4 T cells promoted clearance by killing in-
T cells by treatment with CD8-specific mAb. These exper-
fected epithelial cells in a non-MHC-restricted fashion
iments showed that the endogenous active CD4 T cell
such as Fas/Fas-ligand interaction, activation of innate
response on its own (in conjunction with innate defense
defense mechanisms such as macrophages, neutrophils,
mechanisms) is incapable of resolving a pulmonary in-
and NK cells, release of cytokines with antiviral activities,
fection with the influenza type A virus PR8.
and/or promotion of a T-dependent anti-viral antibody
response.
MATERIAL AND METHODSWe have previously shown that infected athymic nude,
but not T and B cell-deficient SCID, mice could be cured
Mice
by adoptive transfer of virus-specific CD4 T cell clones
(Scherle et al., 1992) and that infected SCID mice could BALB/c mice were purchased from Jackson Labora-
be cured by treatment with anti-viral antibody (Palladino tories (Bar Harbor, ME) or Harlan Sprague Dawley (India-
et al., 1995). These observations are consistent with the napolis, IN). Two homozygous male mMT mice were
kindly provided by the Institute for Genetics (Cologne,
FRG) through L. Shultz (Jackson Laboratory). mMT mice1 To whom correspondence and reprint requests should be ad-
dressed. are B cell deficient because of disruption of the gene
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coding for membrane IgM (Kitamura et al., 1991). They jections of purified CD8-specific mAb 53-6.72 in 0.2 ml
phosphate-buffered saline (PBS), the first injection beingwere backcrossed to BALB/c. After the sixth backcross,
a line homozygous for the mMT disruption was generated 200 mg and all subsequent injections 100 mg. Control
mice received an analogous treatment with purified rat-by intercrossing (termed BALB/c-mMT). Mice were main-
tained in microisolators under specific pathogen-free Ig or the isotype-matched (IgG2a) rat mAb R1.3-12. Three
days after initiation of the CD8 depletion, anesthetizedconditions.
mice (i.p. injection of 0.2 ml ketamine [10 mg/ml]/xylazine
Viruses [2 mg/ml]) were infected by intranasal inhalation of 30
ml PR8 (100 TCID50). Mice were euthanized by i.p. injec-Influenza type A virus strain A/PR/8/34 (H1N1) (PR8)
was originally obtained from Mt. Sinai Hospital (New tion of ketamine/xylazine and subsequent exsanguina-
tion by heart puncture. Lung, lymph nodes, and spleenYork). The infectious stock used in this study was grown
in the allantoic cavity of embryonated hen’s eggs and were harvested. One lung lobe was immediately frozen
for subsequent determination of virus titer, which wascontained 108.4 TCID50 (50% tissue culture infectious dose
for Madin Darby canine kidney (MDCK) cells) and 107.7 done as described (Palladino et al., 1995), and one lobe
was used for isolation of lung parenchymal cells for mea-MID50 (50% mouse infectious dose) per ml. The infectious
influenza type B virus stock B/Lee/40 (Lee) contained surement of MHC class I-restricted cytotoxic activity.
Cells were isolated from lung and lymphoid tissues as107.8 TCID50/ml. Purified and UV inactivated virus was
prepared as described (Mozdzanowska et al., 1997). described (Liang et al., 1994).
Media and solutions FCM analysis
Iscove’s modified Dulbecco’s medium (Gibco), supple-
The FCM staining procedure was as follows: 25 ml of
mented with 0.05 mM 2-mercaptoethanol, 0.005 mg/ml
cells (0.5 1 106) plus 50 ml of MAb (hybridoma culture
transferrin (Sigma), 2 mM glutamine (JRH Biosciences,
supernatant) were incubated in microfuge tubes on ice
KS), and 0.05 mg/ml gentamicin sulfate (Whittaker, MD)
for 45 min, washed once, resuspended in 50 ml of an
(Isc-CM) was used and further supplemented, as indi-
optimal dilution of FITC-labeled mouse anti-rat Ig mAb
cated, with fetal calf serum (FCS) (HyClone), bovine se-
Rt2-8, incubated on ice for 45 min, washed once, and
rum albumin (BSA) (Sigma), or 5-bromo-2-deoxy-uridine
resuspended in 0.2 ml PBSN-1% BSA, which was the
(BudR, Sigma). Phosphate buffered saline containing
diluent and wash fluid used in these assays. Samples
0.04% NaN3 (PBSN) was supplemented, as indicated, were analyzed with an Ortho Cytofluorograf System 50,
with BSA.
connected to a Model 2150 data handling system (Ortho
Diagnostic System, Inc., MA). The gating was set by for-Cell lines and antibodies
ward and right-angle scatter for viable lymphocytes and
MDCK and A20 were maintained in Isc-CM–5% FCS.
2000 events were analyzed.
P1.HTR (Woegel et al., 1987), a cell line derived from the
P815 mastocytoma line, was maintained in Isc-CM-BudR Analysis of CD8 T cell cytotoxic activity
(0.1 mg/ml). DA-1, an IL-3 and GM-CSF-responsive my-
eloid cell line, was maintained in Isc-CM–FCS (5%) sup- Target cells were prepared as follows: P1.HTR cells
were resuspended at 2 1 106 cells/ml in Isc-CM (withoutplemented with IL-3 (250 U/ml). IL-3, IL-4, and IFN-g se-
creting cell lines had been obtained from Karasuyama serum). Virus (PR8 or B/Lee)-containing allantoic fluid
(106.5 TCID50/106 cells) was added and the cells incu-and Melchers (Karasuyama and Melchers, 1988). The
following hybridoma antibodies were used: R1.3-12 (rat bated for 1 h at 377 with occasional rocking. The culture
was diluted fivefold with Isc-CM–5% FCS and incubatedanti-mouse IgG2b), 53-6.72 (rat anti-mouse CD8, ATCC
TIB 105), GK1.5 (rat anti-mouse CD4, ATCC TIB 207), M1/ overnight (16 h) at 327. Aliquots (8 ml) of the culture
were transferred to 15-ml centrifuge tubes. One hundred9.3.4.HL.2 (rat anti-mouse CD45, ATCC TIB 122), 187.1
(rat anti-mouse ck , ATCC HB 58), RA3-3A1/6.1 (CD45R- percent Percoll (Pharmacia) was added to give a final
concentration of 33%, the suspension underlayed withB220, ATCC TIB 146). Rt2-8 is a murine hybridoma spe-
cific for a determinant shared by all rat mAbs included 2 ml of 70% Percoll and spun for 10 min at 600 g at
room temperature. The cells at the 33%/70% interfacein this analysis. The precise nature of this shared deter-
minant is not known. Purified Rt2-8 was labeled with were harvested, diluted in Isc-CM–FCS (5%), pelleted,
and resuspended at 107/ml in the above medium. TheFITC by means of the FluoroTag FITC conjugation kit
(Sigma, St. Louis, MO) according to the protocol recom- desired number of cells was incubated for 45 min at 377
with 51Cr (0.1 mCi/106 cells, ICN), washed, and dispensedmended by the manufacturer.
at 104 cells per well into round-bottom microtiter plates.
CD8 T cell-depletion and infection of mice Lung parenchymal cells were prepared as described and
dispensed into the plate to give the desired effector:tar-Mice (8- to 12-week-old) were depleted of CD8 T cells
by repetitive (5- to 6-day interval) intraperitoneal (i.p.) in- get (E:T) ratios. The plates were briefly spun to deposit
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the cells into the bottom of the wells and the amount of strain to the B10D2 mouse strain. In this experiment,
CD8-depleted and control mMT (0/0) mice were com-51Cr released into 100 ml of medium (1/2 of total culture
volume) was determined after 4 h of incubation at 377. pared to CD8-depleted and control mMT (//0) and
(///) littermates. Experiments 2 and 3 were performedThe percentage of specific release was computed as
described (Scherle et al., 1992). with a BALB/c-m MT (0/0) mouse line that was gener-
ated after the sixth backcross to BALB/c. In all experi-
ments, mice received a total RT infection with 15– 45Analysis of CD4 T cell activities
MID50 of PR8 and the status of the infection was deter-
CD4 T cell activity was assessed by measuring cyto- mined 7, 11, and 17 or 18 days later.
kine secretion in 0.2-ml restimulation cultures set up in Table 1 shows that mMT mice contained, as expected
96-well flat-bottom microtiter plates. The medium was (Kitamura et al., 1991), only few B cells (B220/) in second-
Isc-CM (without serum). Stimulator cells were prepared ary lymphoid tissues and, as reported (Kitamura et al.,
as follows: A20 cells in Isc-CM were incubated for 1 h 1991), the few B220/ cells detected expressed this anti-
at 377 with purified and UV inactivated virus, 350 ng/ gen at decreased density compared to B cells from nor-
106 cells. The suspension was then irradiated (4400 rad) mal mice (data not shown). Although these mice have,
and the cells pelleted, resuspended in Isc-CM, and dis- on average, greatly reduced B cell function, the defect
pensed into microtiter plates to give 105 cells/well. Re- shows some leakiness, which manifested itself most
sponder cells isolated from mediastinal lymph nodes prominently in readily detectable though still subnormal
(MedLN) and spleen were then added at various re- concentrations of IgG2a and IgG2b in serum (our unpub-
sponder cell concentrations (104 to 106/well, several rep- lished observations). In spite of this leakiness, the mMT
licates per responder cell concentration) and the cultures mice described in these studies failed to mount anti-viral
(0.2 ml total volume) incubated for 24 h at 377. Cell-free antibody responses that exceeded 0.2% of the response
culture medium was then harvested for measurement of of intact mice (data not shown). However, unequivocal
cytokine concentration. responses, some amounting to more than 1% of the nor-
IL-3/GM-CSF was measured by means of the DA-1 mal response, were sporadically observed at later time
bioassay. Aliquots (50 ml) of DA-1 cells (4 1 105/ml Isc- points (our unpublished observations). Table 1 also dem-
CM–FCS (2%)) were added to 50 ml of test sample dilu- onstrates that the CD8 T cell-depletion protocol used
tions, usually in four replicates, in flat-bottom 96-well here resulted in strong and sustained depletion of CD8
microtiter plates. The plates were incubated for 2 days T cells. It is of note also that only insignificant numbers
and the concentration of viable DA-1 cells determined (2%) of cells with bound treatment mAb were detect-
by MTT assay as described (Haberman et al., 1990). Each able in these mice at both time points (data not shown).
assay was standardized by a parallel titration of a sample Effective depletion of CD8 T cells was demonstrated also
of known IL-3 concentration. The IL-3/GM-CSF concen- by measuring cytotoxic activity exhibited by the pulmo-
tration is expressed in units/ml (1 U  10 pg). nary cellular infiltrates (Fig. 1). Although low cytotoxic
IL-4 concentration was measured by capture ELISA activity was detectable in mMT (-CD8) mice 7 days after
using plate-bound mAb 11B11 as capture reagent and infection, it was significantly smaller than in mMT (con-
biotinylated anti-IL-4 mAb BVD6-24G2 (PharMingen) as trol) and BALB/c mice and had disappeared by day 11.
measuring reagent. The assay was developed by se- It is noteworthy also that mMT (control) and BALB/c mice
quential incubation with Streptavidine-AP (Sigma) and developed quite similar CTL activity in their lungs, indi-
pNPP (Sigma) and optical density read in an ELISA cating that B cells are not important for induction of influ-
reader (Molecular Devices) at A405 – 750 . The threshold enza virus-specific CD8 T cell responses (Topham et al.,
sensitivity of the assay was 50 pg/ml. 1996a).
IFN-g concentration was measured by capture ELISA Table 2 shows the course of the infection in these
using plate-bound R4-6A2 mAb for capture and biotinyl- mice. It is evident, first, that 90% of B- and CD8 T-cell
ated mAb XMG1.2 (PharMingen) as detecting reagent. containing mice, (///) and (//0) littermates in experi-
The assay was developed and read as above. The ment 1 and BALB/c mice experiments 2 and 3, had
threshold sensitivity was 200 pg/ml. cleared the infection by day 11. Virus clearance appeared
to be somewhat delayed in CD8- or B cell-deficient mice,
RESULTS which is in general agreement with previous reports
(Bender et al., 1992; Graham and Braciale, 1996; DohertyB cell-deficient mMT mice cannot recover from
et al., 1997). Importantly, however, none of 20 BALB/c-a pulmonary infection with PR8 if they
mMT (-CD8) mice managed to clear the infection; all con-are depleted of CD8 T cells
tained high virus titers in their lungs on day 11, showed
a high rate of mortality, particularly between 10 and 18Three challenge experiments were performed. Experi-
ment 1 was performed with mice generated by brother – days after infection, and, if they survived until day 17 to
18, showed further increases in the titer of virus in theirsister matings after the second backcross of the mMT
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TABLE 1
Lymphocyte Composition in Experimental Mice
Percentage of cells
CD4/ CD8/ B220/
Donor mouse Tissue Day 7 Day 11 Day 7 Day 11 Day 7 Day 11
BALB/c MedLN 36 28 15 9 32 37
Spleen 23 18 11 9 49 36
BALB/c(0CD8) MedLN nd 45 nd 1 nd 26
BALB/c-mMT MedLN 70 nd 28 nd 1 nd
Spleen 34 28 16 13 3 5
BALB/c-mMT(0CD8) MedLN 82 85 3 0 1 1
Spleen 45 52 1 0 2 4
Note. MedLN and spleens were obtained 7 or 11 days after total RT infection with 10 MID50 of PR8. The tissues of four to five mice within
each group were pooled prior to isolation of cells. FCM analysis was performed as indicated under Materials and Method, using GK1.5 and 536.72
for detection of CD4 and CD8 T cells, respectively, and RA3-3A1 for detection of B220 positive cells. Rat mAb was detected with FITC-labeled mAb
Rt2-8. Cell recovery from these mice is shown in Table 3.
lungs. Taken together, these observations indicate that in conjunction with innate defense mechanism. An analo-
gous study by Topham and Doherty (1997) in which re-B cells make an important and perhaps indispensable
contribution in recovery of CD8 T cell-deficient mice and covery from the less pathogenic X31 virus infection was
tested, provided similar data in that only 10% of CD8-that CD4 T cells are incapable of resolving this infection
depleted mMT mice managed to clear the infection.
The inability of CD4/ T cells to control the infection
is not due to their ineffective stimulation
in the absence of B cells
As CD4 T cell responses to some antigens have been
reported to be reduced in B cell deficient mice (HayGlass
et al., 1986; Janeway et al., 1987; Ron and Sprent, 1987;
Kurt-Jones et al., 1988; Liu et al., 1995; Constant et al.,
1995; Baird and Parker, 1996; Vella et al., 1996), it was
important to assess the size of the CD4 T cell response
in PR8-infected mMT (-CD8) mice. Table 3 shows that
very similar numbers of CD4 T cells were recovered from
lungs and MedLN of BALB/c and BALB/c-mMT mice. To
show that these cellular CD4 T cell responses also com-
prised comparable numbers of virus specific cells, vari-
ous doses of these cells were restimulated in vitro with
irradiated A20 cells that had been pulsed with a relatively
low dose of UV inactivated PR8 virus. Given that pro-
cessing of inactivated virus through the endocytic path-
way leads to preferential presentation of viral determi-
nants by MHC class II proteins (Morrison et al., 1986;
Germain et al., 1996), these culture conditions would be
expected to restimulate preferentially virus-specific CD4
FIG. 1. MHC class I-restricted cytotoxic T cell activity displayed by
T cells. CD4 T cell activation was assessed by measuringlung parenchymal cells. Effector cells were isolated by collagenase
the concentration of IL-3/GM-CSF released into the cul-treatment of lung tissue 7 and 11 days after infection with PR8. The
cells were tested at the indicated E:T ratios (relative to all viable cells) ture media after one day of incubation. Figure 2 shows
in a 4-h 51Cr-release assay against PR8 (filled dots)- and Lee-infected that the cell populations recovered from the various
(open dots) P1.HTR target cells. Lee is a influenza virus strain of type groups of mice 7 and 11 days after infection responded
B which is immunologically non-cross-reactive with the type A strain
comparably in this assay, thus supporting the notion thatPR8. Since P1.HTR target cells are MHC class II negative, only MHC
these mice generated virus-specific CD4 T cell re-class I-restricted T cell activity is measured in this assay. Each dot
shows the mean specific 51Cr release from four replicate cultures. sponses of comparable strength.
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TABLE 2
CD8-Depleted mMT Mice Cannot Clear the Pulmonary Infection
Day after Lung virus titer log10 Cumulative mortality
Experiment Group infection Cured/tested (mean { SEM (n)) (%)
1 Lm (//) 11 3/3 0 0
Lm (//) (0CD8) 11 2/2 0 0
mMT 11 2/3 4.1 (1) 0
mMT (0CD8) 11 0/3 5.1 { 0.4 (3) 0
mMT (0CD8) 18 0/4 5.7 (1) 75
2 BALB/c 11 4/4 0 0
BALB/c-mMT 11 0/4 1.9 { 0.3 (4) 0
BALB/c-mMT (0CD8) 11 0/4 5.6 { 0.2 (4) 0
BALB/c-mMT (0CD8) 17 0/4 7.0 { 0.8 (2) 50
3 BALB/c 11 3/4 1.6 0
BALB/c (0CD8) 11 1/5 1.5 { 0.1 (4) 0
BALB/c-mMT (0CD8) 11 0/5 6.6 { 0.1 (3) 40
Note. The mice used in experiment 1 are from brother/sister matings after the second backcross of mMT mice to the B10D2 strain and in
experiments 2 and 3, mice obtained after the sixth backcross of mMT to the BALB/c strain. Mice were depleted of CD8 T cells (0CD8) by treatment
with rat anti-CD8 mAb 536.72 3 days before and 1, 6, and 12 days after total RT infection with 15 MID50 (experiments 1 and 2) or 45 MID50 (experiment
3) of PR8. Virus titer in lung extracts was determined at the indicated time points. Failure to detect virus after inoculation of undiluted lung extract
(2 1 50 ml) into the allanoic cavity of embryonated chicken eggs was considered to indicate complete clearance of the infection.
As CD4 T cells of type 1 have been reported to be DISCUSSION
more effective in promoting recovery than CD4 T cells of
Previous studies have established that mice whichtype 2 (Graham et al., 1994; Moran et al., 1996), we also
lack CD8 T cells can recover from an influenza type Atested whether the presence or the absence of B cells
virus infection (Eichelberger et al., 1991; Bender et al.,may have altered the type of the response. As shown in
1992; Scherle et al., 1992), though less effectively thanTable 4, MedLN and lung cells from all groups of mice
immunologically intact mice (Bender et al., 1992). Thisreleased comparable amounts of IFN-g and no detect-
study was conducted to identify the mechanism(s) byable IL-4 upon restimulation with PR8-pulsed A20 cells
which the infection is being resolved in this situation.in vitro, thus providing no evidence for a significant
There are several conceivable mechanism(s) that couldchange in type. In sum, BALB/c-mMT (-CD8) mice ap-
operate here, including (1) contact-dependent killing ofpeared to have generated CD4 T cell responses that
infected cells by cytotoxic CD4 effectors (Hou et al.,were equivalent in size and type to the ones generated
1993), (2) inhibition of virus replication by release of cyto-in BALB/c and mMT mice. It therefore appears that even
kines with anti-viral activities such as IFN-g and TNF-astrong CD4 T cell responses of type 1 are ineffective, on
(Ramsay et al., 1993), (3) recruitment and activation oftheir own, in promoting recovery from this infection.
components of the innate defense system such as NK
cells and macrophages (Doherty et al., 1992), and (4)
TABLE 3 promotion of the T-dependent antibody response
Total Cell Recovery from MedLN and Lungs of Infected Mice (Scherle et al., 1992). There is not much current informa-
tion about this issue, except for the demonstration that
Average cell recovery (11006) per mouse CD4 T cells can promote clearance of the infection in
7 days after infection
MHC class II-negative chimeric hosts (Topham et al.,
1996b), which shows that an MHC restricted recognitionMed LN Lung
of infected epithelial cells by CD4 effector T cells is not
Donor mouse Total CD4 Total CD4 required for recovery and is in contrast to virus clearance
mediated by CD8 T cells (Hou and Doherty, 1995; Doherty
BALB/c 9.9 3.5 5.5 0.7
et al., 1997). Another study pointed to the contribution ofBALB/c-mMT 4.9 3.4 4.2 0.5
CD4 T cells to clearance via cytokine secretion by show-BALB/c-mMT(0CD8) 5.3 4.3 3.9 0.5
ing that virus clearance was delayed by 3–4 days, though
Note. The cell recovery data were obtained from two independent not prevented, if CD8-deficient mice were treated with
experiments, each comprising five and three mice per group, respec- anti-IFN-g antibody (Sarawar et al., 1994); CD4 T cells
tively. Within each group, MedLN or lungs were pooled prior to isolation
are an important producer of IFN-g in this situationof cells. Total indicates the number of viable cells (trypan blue negative)
(Doherty et al., 1992; Baumgarth et al., 1994). The presentrecovered per mouse. The number of CD4/ cells was computed on the
basis of the FCM analysis (Table 1) performed on each cell preparation. study further clarifies the question of how CD4 T cells
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tion of the CD4 T cell response in vivo. Prior evidence
on this issue is ambiguous in that examples of both
diminished (Ron and Sprent, 1976; HayGlass et al., 1986;
Janeway et al., 1987; Kurt-Jones et al., 1988; Constant et
al., 1995; Liu et al., 1995; Baird and Parker, 1996; Vella
et al., 1996) and unaltered (Sunshine et al., 1991; Epstein
et al., 1995; Phillips et al., 1996; Topham et al., 1996a)
CD4 T cell responses in B cell-deficient mice have been
reported. We found that the CD4 T cell response to influ-
enza virus infection was not measurably diminished in
B cell-deficient mice (Table 2; Fig. 1), which is in agree-
ment with the study of Topham et al. (1996a). Another
possible consequence of a change in stimulator cell pop-
ulation could be the deviation of the CD4 T response
toward a distinct cytokine secretion profile (Fitch et al.,
1993). Current evidence indicates that CD4 T cell re-
sponses of type 2 (Th2) are less effective in promoting
recovery than Th1 (Graham et al., 1994; Moran et al.,
1996) and may even be harmful (Graham et al., 1994).
However, since B cells have been reported to induce
preferentially Th2 responses (Fitch et al., 1993; Saoudi
et al., 1995; Taylor-Robinson and Phillips, 1996; Stock-
inger et al., 1996; Macaulay et al., 1997), their absence
would be expected to direct the response toward the
FIG. 2. IL-3/GM-CSF secretion by MedLN after restimulation in vitro. more effective Th1, which dominates already the re-
MedLN cells, obtained 7 or 11 days after infection, were cultured at sponse of intact mice (Carding et al., 1993). It is not
various doses with A20 cells pulsed with UV-inactivated PR8. Re-
surprising, therefore, that the response of B cell-deficientsponder cell doses give the number of CD4 T cells per milliliter of
mice was not measurably different in type from the re-culture, as determined by FCM analysis of the various cell preparations.
Each culture contained 0.2 ml. The responders are from BALB/c (cir- sponse of intact mice (Table 3). Thus, influenza virus
cles), BALB/c-mMT (squares), and BALB/c-mMT (-CD8) (triangles) mice. infection induced an effective CD4 T cell response in the
The concentration of IL-3/GM-CSF in culture media was determined absence of B cells. This leaves the induction of a T-
by the DA-1 bioassay after 24 h of incubation.
dependent anti-viral antibody response as the likely ex-
planation for the requirement of B cells in the CD4-depen-
dent recovery process. Consistent with this conclusionpromote clearance in the absence of CD8 T cells by
is our previous finding that infected SCID mice can beshowing that an interaction between CD4 T and B cells
cured by treatment with anti-viral antibodies (Palladinois an indispensable component of the CD4-dependent
et al., 1995; Mozdzanowska et al., 1997).recovery process.
The severity of the virus challenge is obviously anThe CD4 T–B cell interaction might be required for
two reasons. (1) B cells may be needed for optimal activa- important factor when one tries to define the efficacy of
TABLE 4
Cytokine Secretion by MedLN and Lung Cells
IFN-g (ng/ml) IL-4 (ng/ml)
Responder cells Stimulator cells MedLN Lung MedLN Lung
BALB/c A20 0.2 (0.1) 0.8 (2.1) 0.05 0.05
BALB/c A20-PR8 6.1 (4.2) 4.2 (33.0) 0.05 0.05
BALB/c-mMT A20-PR8 4.3 (1.5) 4.0 (33.6) 0.05 0.05
BALB/c-mMT (0CD8) A20-PR8 6.1 (1.9) 5.5 (42.9) 0.05 0.05
Note. MedLN and lung cells obtained 7 days after infection from the indicated groups of mice were cultured in vitro (4 1 106 cells/ml in the case
of MedLN and 3 1 106/ml in the case of lung cells) with PR8-pulsed or nonpulsed A20 cells and IFN-g and IL-4 concentrations in the culture media
were determined by ELISA after 24 h of incubation. The data are the means of two to three independent experiments. The data in parentheses are
computed values that take into account different frequencies of CD4 T cells in the responder cell preparations (see Tables 1 and 3) and are
expressed relative to cultures containing 106 CD4 T cells/ml.
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host defense systems: the more severe the challenge in other cases harmfully (Leung and Ada, 1982; Taylor et
al., 1990; Scherle et al., 1992; Graham et al., 1994). How-the higher the demands on the host’s defenses. The PR8
virus strain is quite pathogenic for mice and the chal- ever, since most of these studies were performed with
at least partially immunocompetent recipients, they didlenge dose used here (15–45 MID50) represents approxi-
mately 0.1 LD50 for immunologically intact mice. However, not reveal how much the transferred CD4 T cells contrib-
uted directly to the final virus clearance. Immunodeficienta poor therapeutic efficacy of CD4 T cells on their own
was also seen in infections with the much less patho- recipients have been used in only few studies. Lightman
et al. (1987) transferred purified CD4 memory T cell popu-genic X31 virus strain (Topham and Doherty, 1997). Thus,
the low therapeutic efficacy of CD4 T cells in influenza lations into lethally irradiated recipient mice and reported
than one cell preparation cured the infection while ainfection appears to be a general phenomenon.
The low therapeutic efficacy of CD4 effector T cells is second and apparently purer preparation was ineffective.
We have transferred CD4 T cell clones of type 1 intosurprising in view of the fact that the infection induces
a strong CD4 T cell response which is characterized by infected SCID mice and found that this treatment had
either no measurable effect or resulted only in temporarysubstantial production of IFN-g and TNF-a/b (Table 3,
Carding et al., 1993; Hou et al., 1993). These cytokines reduction in virus titer but never in recovery from infection
(Scherle et al., 1992, and unpublished observations).exhibit powerful antiviral activities if they are targeted to
infected cells (Ramsay et al., 1993). The importance of The previous demonstration that infected SCID mice
can be cured by treatment with anti-HA antibodies of IgGMHC-mediated targeted release of cytokines by effector
T cells has been demonstrated also by Kundig et al. isotypes (Palladino et al., 1995; Mozdzanowska et al.,
1997) is consistent with a crucial role of the T-dependent(1993). In rats, and presumably also in mice, the epithelia
of the RT do not express MHC class II protein under antibody response in the recovery of CD8-deficient mice.
Recent studies showed that the antibody response playsnormal conditions (except for epithelium overlaying BALT
and type II pneumocytes of alveoli) but class II proteins an important role also in the recovery process of intact
mice (Graham and Braciale, 1996; Gerhard et al., 1997).become induced under inflammatory conditions (IFN-g)
(Steininger and Sickel, 1991). Thus, conditions for MHC- Of note in this context is that antibody secreting cells
(ASC) in draining lymph nodes arise between 4 and 6mediated targeted release of cytokines by CD4 effector
T cells should be fulfilled during infection. days after infection (Justewicz et al., 1995) which coin-
cides with the time when virus titers are dropping. Also,Analogous approaches as described here have been
used to define the therapeutic activities of CD4 T cells we have previously identified a subpopulation of HA-
specific B cells (termed C12) which is characterized byin rotavirus and cytomegalovirus infection. Franco and
Greenberg (1995) reported that JHD mice, a mouse strain (1) use of a restricted set of unmutated V region genes,
(2) rapid maturation to ASC within 5 days, and (3) earlyrendered B cell-deficient because of targeted deletion of
the J region of the Ig heavy chain gene (Chen et al., 1993), or immediate switch to IgG heavy chain isotypes (Kavaler
et al., 1990, 1991). This B cell population accounts forcould not clear a rotavirus infection if they were depleted
of CD8 T cells. McNeal et al. (1995) tested both JHD 25% of the primary response on day 5 and members
of this group have been shown to be highly effectiveand mMT mice and observed minor differences between
these strains in that CD8-depleted JHD mice could not therapeutically in SCID mice (Mozdzanowska et al.,
1997). A similar B cell population has recently been iden-clear the infection while CD8-depleted mMT mice could,
though very slowly. Thus, the findings in rotavirus and tified also in the response of mice to vesicular stomatitis
virus (Kalinke et al., 1996). The rapid kinetics of theseinfluenza virus infection are overall quite similar. By con-
trast, CD4 T cells appear to be capable of controlling responses is consistent with an important role of antibod-
ies in the recovery process.infection of salivary glands with cytomegalovirus, though
not of other tissues such as lung and spleen (Jonjic et
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